Botulinum toxin type A (BT A) treatment is an alternative to strabismus surgery. In this retrospective study the data on 45 esotropic and 49 exotropic patients with concomitant strabismus who were treated with BT A were analysed for dose-effect relationship, the effect of repeat doses and amblyopia on success of botulinum treatment. The esotropic patients were treated with a total of 80 and exotropic patients with 91 injections. The deviations were corrected within 5 degrees of straight in 33% of esotropic and 18% of exotropic patients. In esotropic patients the effect was dose dependent. This relation was not shown in exotropic patients. The repeat doses of BTA corrected the deviation to the same extent as the primary ones for both esotropic and exotropic patients. apart from its commonly encountered paralytic effects, is that it produces effects that are not as predictable and stable as traditional surgery. In this study we analysed our data to investigate the dose-effect relationshp and the effect of repeat doses.
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MATERIALS AND METHODS
In this retrospective study case notes of patients with 5  16  13  7  1  37  5  10  2  1  13  7.5  1  1  2  10  7  2  1  10  15  7  2  1  10  20  5  3  8   Total  45  23 type A toxin haemagglutin, Port on Products, UK).
The BT A was diluted so that regardless of the dose a bolus of 0.1 ml could be injected. The dose applied ranged from 2.5 to 20 units. This retrospective study covers a 10 year period. Initially 2.5 units of BT A were injected into each patient regardless of the angle of deviation. Upon realising that the improve ments in deviation were not satisfactory, the BTA dose applied was increased to 5 and then to 10, 15
and 20 units. We did not set up a range of deviations for which we would apply a specific BT A dose; the decision for re-injection was given if the post treatment deviation was greater than 5° of straight after a follow-up period of 6 months. Some patients who were satisfied with their appearance refused to have a repeat injection.
The esotropic and exotropic patients were eval uated separately. Two methods were used to evaluate the effect of BT A in strabismus. 1 The first was to calculate the percentage reduction in the pre treatment deviation after the paralytic effect dis appeared, using the following formula:
Pre-treatment deviation-Post-treatment deviation ���==����������-=� X 100 Pre-treatment deviation
The second method was to determine whether the post-treatment deviation was within 5° of straight.
Those patients having a post-treatment deviation within 10 degrees of straight were evaluated as cosmetically successful. The esotropic and exotropic patients were grouped according to the dose of BT A applied and the number of injections performed.
We investigated the effect of repeat doses on the percentage reduction of the initial deviation (pro vided that the same toxin dose was used) to find out whether there is any cumulative effect of BT A.
Secondly we looked for the effect of a change in We also evaluated the incidence of ptosis with respect to increments in BT A doses. This is the most common paralytic side effect of BT A treatment. for group I, 10% for group II and 9% for group III.
RESULTS

Forty
In none of the patients who had an initial deviation of more than 25 degrees were we able to achieve a post-treatment deviation below 10 degrees. The cosmetic success rates for these exotropic patients were 100% for group I, 20% for group II and 27% for group III (Table VIII, Fig. 2 ). Fig. 2 shows a tendency for less successful outcomes with increasing pre-treatment deviations.
We also evaluated the side effects of botulinum toxin injections. The distributions of patients who had post-injection ptosis, according to dose applied and type of strabismus, are summarised in Table IX. For our esotropic patients the incidence of ptosis after BTA treatment was 40%, 23%, 29%, 10% and 50% for patients receiving 2. We then investigated whether the effect of botulinum treatment was dose dependent-For esotropic patients we found the effect increased The incidence of ptosis for exotropic patients was 14% and that for esotropic patients was 29%. The incidence of ptosis is higher for esotropic patients compared with exotropic patients. It has also been noted previously by several authors that ptosis was Post-treatment deviation
Post-treatment deviation the reduction rate appears to be 46%, which is very similar to our results in esotropic patients. Scott, who has the largest botulinum treatment series, Total exotropic patients (n) 10 10 22 7
Post-treatment deviation
Post-treatment deviation The percentage correction of deviation within 5 or 10 degrees of orthophoria with regard to initial deviation in esotropic patients. In a study by Scott et at? it was also shown that better results were obtained when treating esotropia than exotropia regardless of whether previous surgery has O. E. ABBASOGLU ET AL. The percentage correction of deviation within 5 or 10 degrees of orthophoria with regard to initial deviation in exotropic patients. 
